Business

Press Release Mar 21 2026

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Dr. Reddy s Laboratories announces launch of India s first DCGI-approved Semaglutide injection Obeda® for Type 2 Diabetes.".

Dr. Reddy's Laboratories Ltd.March 21, 20263
Press Release Mar 21 2026

About this update from Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Dr. Reddy s Laboratories announces launch of India s first DCGI-approved Semaglutide injection Obeda® for Type 2 Diabetes.". View Attachment

View stock analysis, news, and events for Dr. Reddy's Laboratories Ltd.

More from Dr. Reddy's Laboratories Ltd.

Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose ...

August 4, 2026

Dr. Reddy's Laboratories Ltd. Press Release Aug 01 2026

August 1, 2026

All Dr. Reddy's Laboratories Ltd. news →